SM

Sabby Management Portfolio holdings

AUM $13M
1-Year Return 26.95%
This Quarter Return
-0.75%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$289M
AUM Growth
-$208M
Cap. Flow
-$15.1M
Cap. Flow %
-5.24%
Top 10 Hldgs %
39.85%
Holding
261
New
44
Increased
40
Reduced
57
Closed
60

Sector Composition

1 Healthcare 85.34%
2 Industrials 0.77%
3 Consumer Staples 0.45%
4 Consumer Discretionary 0.43%
5 Technology 0.11%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ALKS icon
151
Alkermes
ALKS
$4.94B
-15,000
Closed -$513K
ALNY icon
152
Alnylam Pharmaceuticals
ALNY
$59.2B
0
AMRN
153
Amarin Corp
AMRN
$317M
-43,540
Closed -$1.33M
ARDX icon
154
Ardelyx
ARDX
$1.57B
-22,278
Closed -$173K
ASRT icon
155
Assertio
ASRT
$76.8M
-26,514
Closed -$1.48M
BHC icon
156
Bausch Health
BHC
$2.72B
0
BMY icon
157
Bristol-Myers Squibb
BMY
$96B
0
BPMC
158
DELISTED
Blueprint Medicines
BPMC
-29,624
Closed -$535K
CARM icon
159
Carisma Therapeutics
CARM
$16.8M
-60,699
Closed -$387K
CLRB icon
160
Cellectar Biosciences
CLRB
$15.9M
-24
Closed -$242K
CRDF icon
161
Cardiff Oncology
CRDF
$144M
-1,181
Closed -$395K
CYCC icon
162
Cyclacel Pharmaceuticals
CYCC
$15.9M
-2
Closed -$628K
CYTK icon
163
Cytokinetics
CYTK
$6.34B
0
DBVT
164
DBV Technologies
DBVT
$245M
-7,000
Closed -$2.28M
DXCM icon
165
DexCom
DXCM
$31.6B
0
EW icon
166
Edwards Lifesciences
EW
$47.5B
0
EXEL icon
167
Exelixis
EXEL
$10.2B
0
GILD icon
168
Gilead Sciences
GILD
$143B
0
GLD icon
169
SPDR Gold Trust
GLD
$112B
0
HALO icon
170
Halozyme
HALO
$8.76B
-60,000
Closed -$568K
HCA icon
171
HCA Healthcare
HCA
$98.5B
0
HRTX icon
172
Heron Therapeutics
HRTX
$201M
0
IONS icon
173
Ionis Pharmaceuticals
IONS
$9.76B
-7,002
Closed -$284K
JNJ icon
174
Johnson & Johnson
JNJ
$430B
0
LAB icon
175
Standard BioTools
LAB
$497M
-139,506
Closed -$1.13M